Classical Pathway of Complement System
Uploaded by
U2000050 STUDENTClassical Pathway of Complement System
Uploaded by
U2000050 STUDENTCommon questions
Powered by AIComplement proteins achieve targeting specificity by remaining inactive unless they bind to pathogen surfaces. Once proteins like C3b bind to a pathogen, they become activated and facilitate further cascade events, including opsonization and membrane attack. This surface binding ensures enzymes do not circulate freely and indiscriminately attack host cells. Regulation proteins such as factor H and decorin prevent complement activation on host cell surfaces .
The classical pathway is crucial due to its role in linking innate and adaptive immunity. Triggered by antigen-antibody binding, it bridges the innate response with adaptive mechanisms. This pathway facilitates opsonization, inflammation, and direct pathogen lysis. Despite overlap with lectin and alternative pathways, its unique integration with adaptive features (antibodies) makes it vital for complex immune challenges and specific pathogen clearances .
If the complement system malfunctions or is improperly regulated, the immune system may fail to clear pathogens efficiently, leading to increased vulnerability to infections. Conversely, excessive or misdirected complement activity can lead to host tissue damage and autoimmune diseases where the system mistakenly targets the body’s own cells .
The complement system, primarily part of the innate immune response, enhances the inflammatory response, and directly lyses pathogens. Its components, such as C3b, opsonize pathogens, marking them for uptake by phagocytes. It can alert and activate the adaptive immune system when innate mechanisms don't successfully eliminate pathogens. For instance, it interacts with antibodies (adaptive immunity) in the classical pathway to form complexes that result in pathogen elimination .
Opsonization in the complement system involves marking pathogens with complement proteins like C3b to enhance recognition and ingestion by phagocytic cells such as macrophages. This process allows for efficient pathogen clearance and is crucial for linking the innate and adaptive immune responses to ensure comprehensive clearance of infections .
Complement proteins are synthesized by various cells, primarily hepatocytes in the liver. Other contributors include monocytes, adipocytes, skin fibroblasts, and epithelial cells. The diverse origin of these proteins ensures a rapid and widespread immune response, as complement proteins are available throughout the body to quickly recognize and respond to pathogens .
The classical pathway begins with the binding of antigen-antibody complexes to C1, which contains subunits C1q, C1r, and C1s. Binding activates C1s, which cleaves C4 and C2 to form C4b2b, known as C3 convertase. This convertase cleaves C3 into C3a and C3b. C3b joins C3 convertase to form C5 convertase, which cleaves C5 into C5a and C5b. C5b initiates MAC formation by binding C6, C7, and later C8 and up to 16 C9 molecules, creating a pore in the pathogen's membrane and causing cell lysis .
Regulation of complement activation via the classical pathway includes various inhibitors and regulatory proteins such as C1 inhibitor, which prevents C1 activation, and decay-accelerating factor that deactivates C3/C5 convertases. Proteins like factor H ensure that C3b is inactivated unless on pathogen surfaces, mitigating the potential for host cell damage and maintaining immune balance .
The complement system balances its protective immune roles and potential host tissue damage with precise regulatory mechanisms. It involves zymogens, which activate only on pathogen surfaces, preventing active enzymes from affecting host cells. C3b and C4b proteins become inactive unless they bind pathogens promptly. Several proteins like C1 inhibitor, decay-accelerating factor, factor H, vitronectin, and protectin regulate complement activation and prevent unnecessary tissue damage .
C3a and C5a, both cleavage products of the complement cascade, function as anaphylatoxins. C3a is released into circulation to recruit neutrophils and other phagocytes to infection sites, enhancing the inflammatory response. Similarly, C5a also recruits phagocytes, amplifying the immune response against pathogens .